Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Optimer and Cubist Pharma to copromote Dificid for Clostridium difficile infection

April 8, 2011

PRISM and Eisai collaborate on PRI-724

April 8, 2011

Millenium Pharma and Sunesis Pharma enter agreement for kinase inhibitors in oncology

April 8, 2011

Sangamo and CHDI Foundation join to develop ZFP therapy for Huntington's disease

April 8, 2011

Celgene and ProMetic Life Sciences enter agreement for protein technologies

April 6, 2011

Aragen Bioscience receives NIAID subcontracts to develop mAbs for infectious diseases

April 6, 2011

MedImmune enters strategic collaboration with Inserm Transfert

April 6, 2011

OncoSec Medical and Inovio enter agreement for electroporation technology for cancer

April 6, 2011

Morphotek acquires tumor-targeting peptide platform from TransMolecular

April 5, 2011

Astellas licenses three agents to Cardeus Pharma

April 5, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...